Lataa...
Talimogene laherparepvec: First in class oncolytic virotherapy
Oncolytic viruses represent a novel drug class in which native or modified viruses mediate tumor regression through selective replication within and lysis of tumor cells as well as induction of systemic antitumor immunity capable of eradicating tumor at distant, uninjected sites. Talimogene laherpar...
Tallennettuna:
| Julkaisussa: | Hum Vaccin Immunother |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893211/ https://ncbi.nlm.nih.gov/pubmed/29420123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1412896 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|